Being an old pharma guy I have to say this. There is a difference between numerical difference and statistical significance. I don't know enough about DXO marks methodology to make a definitive statement but a one point difference may represent a trend toward statistical significance without actually achieving it. Since the folks at DXO seem fairly quant driven it would be interesting to hear their thoughts on this.